Spots Global Cancer Trial Database for ductal carcinoma in situ
Every month we try and update this database with for ductal carcinoma in situ cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Registry Study of Breast Microseed Treatment | NCT02701244 | Breast Neoplasm... | Permanent Breas... | 50 Years - | Concure Oncology-Breast Microseed Inc. | |
| Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery | NCT02391194 | Breast Cancer | AVB-620 | 18 Years - | Avelas Biosciences, Inc. | |
| Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | NCT00669747 | Ductal Carcinom... | Carboplatin i.d... Carboplatin i.d... Normal Saline | 18 Years - | Windy Hill Medical, Inc. | |
| Impact of Radiation Therapy on Breast Conservation in DCIS | NCT02248662 | DCIS | 21 Years - | Dana-Farber Cancer Institute | ||
| Intraoperative Radiation Therapy (IORT) in DCIS | NCT03216421 | Breast Cancer Ductal Carcinom... | Quality of Life... | 18 Years - | Columbia University | |
| Hong Kong Breast Cancer Study | NCT02889458 | Breast Cancer Ductal Carcinom... | Not Provided | 18 Years - | The University of Hong Kong | |
| The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage | NCT02121873 | Breast Cancer Preneoplastic C... Ductal Carcinom... | Nipple aspirato... Ductal lavage m... Blood draw | 18 Years - | Atossa Therapeutics, Inc. | |
| The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness | NCT02909426 | Invasive Cancer Ductal Carcinom... | Ultrasonography Digital mammogr... | 40 Years - 59 Years | Soonchunhyang University Hospital | |
| Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ | NCT02908178 | Ductal Carcinom... | Sentinel lymph ... | 67 Years - 94 Years | Yale University | |
| Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine) | NCT04341129 | Breast Neoplasm... Breast Diseases Breast Fibroade... Breast Cancer | Abbreviated MRI... | 18 Years - 80 Years | University of Chicago | |
| Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer | NCT02127073 | Breast Cancer Ductal Carcinom... | Intranasal Oxyt... | 18 Years - | Montefiore Medical Center | |
| The Prone Breast Radiation Therapy Trial | NCT01815476 | Ductal Carcinom... Invasive Breast... | Radiation Thera... | - | Toronto Sunnybrook Regional Cancer Centre | |
| Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System | NCT06133647 | Ductal Carcinom... Invasive Lobula... | managing Male B... | 18 Years - 85 Years | Methodist Health System | |
| A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ | NCT01628536 | Ductal Carcinom... | Black cohosh | 18 Years - 90 Years | Yale University | |
| Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine) | NCT04341129 | Breast Neoplasm... Breast Diseases Breast Fibroade... Breast Cancer | Abbreviated MRI... | 18 Years - 80 Years | University of Chicago | |
| Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ | NCT04666961 | Ductal Carcinom... Extensive Disea... Mastectomy | Tamoxifen 20 mg Anastrozole 1Mg... | 40 Years - | Institut Cancerologie de l'Ouest | |
| Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion | NCT06033092 | BRCA Mutation PALB2 Gene Muta... Ductal Carcinom... Lobular Carcino... ATM Gene Mutati... CHEK2 Gene Muta... CDH1 Gene Mutat... RAD51C Gene Mut... RAD51D Gene Mut... | Tamoxifen 10 mg... Intermittent ca... Step counter De... | 18 Years - 70 Years | European Institute of Oncology | |
| Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ | NCT05218044 | Ductal Carcinom... | Cryoablation | 18 Years - | Glendale Adventist Medical Center d/b/a Adventist Health Glendale | |
| Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms | NCT01194440 | Ductal Carcinom... Estrogen Recept... Progesterone Re... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | letrozole zoledronic acid | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion | NCT06033092 | BRCA Mutation PALB2 Gene Muta... Ductal Carcinom... Lobular Carcino... ATM Gene Mutati... CHEK2 Gene Muta... CDH1 Gene Mutat... RAD51C Gene Mut... RAD51D Gene Mut... | Tamoxifen 10 mg... Intermittent ca... Step counter De... | 18 Years - 70 Years | European Institute of Oncology | |
| Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer | NCT00742222 | Breast Cancer Carcinoma Lumpectomy Ductal Carcinom... | Electronic Brac... Intracavitary a... | 50 Years - | Xoft, Inc. | |
| Hong Kong Breast Cancer Study | NCT02889458 | Breast Cancer Ductal Carcinom... | Not Provided | 18 Years - | The University of Hong Kong | |
| Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS | NCT02926911 | DCIS Ductal Carcinom... | Surgery Active Monitori... | 40 Years - 99 Years | Alliance Foundation Trials, LLC. | |
| Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) | NCT04985032 | Ductal Carcinom... Invasive Ductal... | stereotactic bo... | 50 Years - 100 Years | RPCR, Inc. | |
| Impact of Radiation Therapy on Breast Conservation in DCIS | NCT02248662 | DCIS | 21 Years - | Dana-Farber Cancer Institute | ||
| Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging | NCT01060085 | Ductal Carcinom... Invasive Breast... | 30 Years - | Dartmouth-Hitchcock Medical Center | ||
| A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ | NCT01628536 | Ductal Carcinom... | Black cohosh | 18 Years - 90 Years | Yale University | |
| An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite" | NCT04349111 | Invasive Ductal... Ductal Carcinom... | Intra-operative... | 40 Years - | Xoft, Inc. | |
| DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment | NCT06075953 | Ductal Carcinom... | Tamoxifen Exemestane Letrozole Anastrazole Testosterone + ... Elacestrant Z-endoxifen | 18 Years - | QuantumLeap Healthcare Collaborative | |
| Excisional Vacuum-Assisted Breast Biopsy | NCT05932758 | Atypical Ductal... Ductal Carcinom... | Vacuum-assisted... Not excisional ... | 18 Years - | European Institute of Oncology | |
| Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ | NCT05218044 | Ductal Carcinom... | Cryoablation | 18 Years - | Glendale Adventist Medical Center d/b/a Adventist Health Glendale | |
| The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure | NCT03375892 | Breast Cancer Ductal Carcinom... Invasive Breast... | Deep Inspiratio... Free breathing ... | 18 Years - | Medical College of Wisconsin | |
| Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity | NCT00886535 | Breast Cancer Ductal Carcinom... | 18 Years - | Milton S. Hershey Medical Center | ||
| Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates | NCT05961280 | Ductal Carcinom... | Mastectomy with... | 19 Years - | Gangnam Severance Hospital | |
| Effects of Diet and Exercise on Ductal Carcinoma in Situ | NCT02224807 | Ductal Carcinom... Breast Cancer | Active Comparat... Experimental: P... | 19 Years - | University of Alabama at Birmingham | |
| Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ | NCT06218303 | Ductal Carcinom... | MUC1 Peptide Va... Hiltonol® Aromatase Inhib... | 18 Years - | University of Pittsburgh | |
| The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. | NCT04248179 | Breast Cancer Ductal Carcinom... | Ropivacaine inj... Saline 0.9% Sufentanil and ... | 18 Years - | Zealand University Hospital | |
| The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness | NCT02909426 | Invasive Cancer Ductal Carcinom... | Ultrasonography Digital mammogr... | 40 Years - 59 Years | Soonchunhyang University Hospital | |
| MRI Characterization of Mammographically Detected DCIS | NCT03495011 | Breast Cancer, ... | Breast MRI Laboratory Biom... | 18 Years - 80 Years | University of Washington | |
| Patient Outcomes From Second Film-readers and Test Threshold Relaxation in Breast Screening | NCT04365114 | Breast Cancer Ductal Carcinom... | Breast Screenin... Breast screenin... Test threshold | 47 Years - 73 Years | University of Warwick | |
| Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer | NCT00742222 | Breast Cancer Carcinoma Lumpectomy Ductal Carcinom... | Electronic Brac... Intracavitary a... | 50 Years - | Xoft, Inc. | |
| Ruxolitinib for Premalignant Breast Disease | NCT02928978 | Ductal Carcinom... Atypical Lobula... Atypical Ductal... Lobular Carcino... | Ruxolitinib Placebo (for Ru... | 18 Years - | Baylor Breast Care Center | |
| Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System® | NCT01644669 | Invasive Ductal... Ductal Carcinom... | Intra-operative... | 40 Years - | Xoft, Inc. | |
| Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer | NCT03669952 | Outcome of Brea... | None interventi... | - | Omphis Foundation | |
| Breast MRI as a Preoperative Tool for DCIS | NCT00605982 | Breast Cancer Ductal Carcinom... | MRI | 21 Years - 59 Years | Memorial Sloan Kettering Cancer Center | |
| Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer | NCT02137252 | Invasive Breast... Ductal Carcinom... Lobular Carcino... Lobular Carcino... Fatigue Related... | Naltrexone Sugar Pill | 18 Years - | Dana-Farber Cancer Institute | |
| Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity | NCT00886535 | Breast Cancer Ductal Carcinom... | 18 Years - | Milton S. Hershey Medical Center | ||
| Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer | NCT01138553 | Invasive Breast... Ductal Carcinom... | Mifepristone | 18 Years - | University of California, San Diego | |
| Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml® | NCT01448447 | Breast Cancer Ductal Carcinom... | Mammosite ML Mammosite ML | 45 Years - | Mercy Research | |
| Excisional Vacuum-Assisted Breast Biopsy | NCT05932758 | Atypical Ductal... Ductal Carcinom... | Vacuum-assisted... Not excisional ... | 18 Years - | European Institute of Oncology | |
| Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | NCT00496808 | Ductal Carcinom... | Herceptin (Tras... | - | M.D. Anderson Cancer Center | |
| Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | NCT00496808 | Ductal Carcinom... | Herceptin (Tras... | - | M.D. Anderson Cancer Center | |
| Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ | NCT04666961 | Ductal Carcinom... Extensive Disea... Mastectomy | Tamoxifen 20 mg Anastrozole 1Mg... | 40 Years - | Institut Cancerologie de l'Ouest | |
| Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer | NCT00742222 | Breast Cancer Carcinoma Lumpectomy Ductal Carcinom... | Electronic Brac... Intracavitary a... | 50 Years - | Xoft, Inc. | |
| An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite" | NCT04349111 | Invasive Ductal... Ductal Carcinom... | Intra-operative... | 40 Years - | Xoft, Inc. | |
| Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast | NCT00165256 | Ductal Carcinom... | Observation | 18 Years - | Dana-Farber Cancer Institute | |
| A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ | NCT01060345 | Ductal Carcinom... | Polyphenon E | 18 Years - | University of Chicago | |
| Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM) | NCT04866992 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Ductal Carcinom... Prognostic Stag... Prognostic Stag... BRCA1 Mutation BRCA2 Mutation | 18 Years - | University of Texas Southwestern Medical Center | ||
| Subzero and Scorpion Trial | NCT05032079 | Ductal Carcinom... | cryoablation | 18 Years - 95 Years | Larkin Community Hospital | |
| Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS) | NCT03775213 | Ductal Carcinom... | Decision Suppor... Decision Suppor... | 50 Years - 79 Years | Duke University | |
| Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms | NCT01194440 | Ductal Carcinom... Estrogen Recept... Progesterone Re... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | letrozole zoledronic acid | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ | NCT06218303 | Ductal Carcinom... | MUC1 Peptide Va... Hiltonol® Aromatase Inhib... | 18 Years - | University of Pittsburgh | |
| Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS | NCT02926911 | DCIS Ductal Carcinom... | Surgery Active Monitori... | 40 Years - 99 Years | Alliance Foundation Trials, LLC. | |
| Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery | NCT03535506 | DCIS | Palbociclib | 18 Years - | Georgetown University | |
| Patient Outcomes From Second Film-readers and Test Threshold Relaxation in Breast Screening | NCT04365114 | Breast Cancer Ductal Carcinom... | Breast Screenin... Breast screenin... Test threshold | 47 Years - 73 Years | University of Warwick | |
| Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy | NCT03430765 | Persistent Post... Breast Cancer F... Ductal Carcinom... | Acceptance and ... | 18 Years - 100 Years | University of Iowa | |
| Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS) | NCT03775213 | Ductal Carcinom... | Decision Suppor... Decision Suppor... | 50 Years - 79 Years | Duke University | |
| Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | NCT00496808 | Ductal Carcinom... | Herceptin (Tras... | - | M.D. Anderson Cancer Center | |
| BrUOG 351: PRE-OPERATIVE APBI USING NIBB | NCT03437915 | Breast Cancer Invasive Breast... Ductal Carcinom... | NIBB: accuboost Partial mastect... | 60 Years - | Brown University | |
| Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) | NCT04797299 | DCIS | 46 Years - | Ontario Clinical Oncology Group (OCOG) | ||
| Living Well After Breast Surgery | NCT03834532 | Breast Cancer F... Stage I Breast ... Stage II Breast... Stage III Breas... Ductal Carcinom... Ductal Breast C... Lobular Breast ... | Breast reconstr... Educational web... | 18 Years - | University of Texas at Austin | |
| A Registry Study of Breast Microseed Treatment | NCT02701244 | Breast Neoplasm... | Permanent Breas... | 50 Years - | Concure Oncology-Breast Microseed Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
